PeptiMatrix

Nottingham, United Kingdom Founded: 2022 • Age: 4 yrs
Provider of a peptide hydrogel platform for 3D cell culture
Annual revenue - Latest available
Total funding $906,411 1 rounds
Employees - Tracked headcount
Investors - Known backers
Products 1 Services tracked
Competitors 10 Brand Intelligence

About PeptiMatrix

PeptiMatrix is a company based in Nottingham (United Kingdom) founded in 2022. PeptiMatrix has raised $906.41 thousand across 1 funding round. PeptiMatrix offers products and services including PeptiMatrix™. PeptiMatrix operates in a competitive market with competitors including Pluri, Celloid, Mo:re, AIM Biotech and The Well Bioscience, among others.

  • Headquarter Nottingham, United Kingdom
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Peptimatrix Limited
  • Date of Incorporation 31 Mar, 2023
  • Jurisdiction NOTTINGHAM, ENGLAND
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $906.41 K (USD)

    in 1 rounds

  • Latest Funding Round
    $906.41 K (USD), Seed

    Jul 20, 2023

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of PeptiMatrix

PeptiMatrix offers a comprehensive portfolio of products and services, including PeptiMatrix™.

Product name locked
Category locked
Primary

Synthetic peptide hydrogel for 3D cell culture in research applications.

Funding Insights of PeptiMatrix

PeptiMatrix has successfully raised a total of $906.41K through 1 strategic funding round. The most recent funding activity was a Seed round of $906.41 thousand completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by PeptiMatrix

Investments
Premium access

Investment portfolio details for PeptiMatrix

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - PeptiMatrix

Premium access

Detailed financials for PeptiMatrix

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Peptimatrix Comparisons

PeptiMatrix Primary company
Description
Provider of a peptide hydrogel platform for 3D cell culture
Location
Nottingham, United Kingdom
Founded Year
2022
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for PeptiMatrix

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of PeptiMatrix

PeptiMatrix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pluri, Celloid, Mo:re, AIM Biotech and The Well Bioscience, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Next-generation cell-based products are developed across multiple industries.
Locked Locked Locked
3D cell culture solutions for drug development are provided.
Locked Locked Locked
3D cell culture robots are developed for medical research applications.
Locked Locked Locked
Microfluidic 3D cell culture systems are developed and manufactured.
Locked Locked Locked
Develops xeno-free hydrogels for 3D cell culture and personalized medicine applications.
Locked Locked Locked
Glycan analysis services and kits are offered by S-BIO.
Premium access

Detailed competitors of PeptiMatrix

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Peptimatrix

Premium access

Complete news archive for PeptiMatrix

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about PeptiMatrix

PeptiMatrix was founded in 2022 and raised its 1st funding round 1 year after it was founded.

PeptiMatrix is headquartered in Nottingham, United Kingdom.

PeptiMatrix is a funded company, having raised a total of $906.41K across 1 funding round to date.

Established in 2022 in Nottingham, United Kingdom, PeptiMatrix operates within the biotechnology sector. A peptide-based hydrogel platform is developed to enable 3D cell culture environments. This technology supports research in cell biology and tissue engineering by mimicking extracellular matrices. Services focus on supplying materials for laboratory and preclinical applications, with operations centered in the UK to serve global scientific communities.

PeptiMatrix's top competitors include Pluri, Mo:re and Celloid.

PeptiMatrix offers PeptiMatrix™.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available